UnitedHealth Group Faces Steep Regulatory Hurdles as Investors Question Long Term Profitability
For decades, UnitedHealth Group stood as the gold standard of stability in the healthcare sector. As a Dow Jones Industrial Average heavyweight,
by 
Josh Weiner
Josh Weiner